These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29185433)

  • 21. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
    Meade BR; Dowdy SF
    Discov Med; 2009 Dec; 8(43):253-6. PubMed ID: 20040280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic delivery of small RNA using lipid nanoparticles.
    Asai T; Oku N
    Biol Pharm Bull; 2014; 37(2):201-5. PubMed ID: 24492716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivering siRNA with Dendrimers: In Vivo Applications.
    Leiro V; Santos SD; Pego AP
    Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
    Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK
    Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research progress on the development of the strategies for siRNAs delivery in vivo].
    Tang D; Mao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery of RNAi therapeutics: work in progress.
    Miller AD
    Expert Rev Med Devices; 2013 Nov; 10(6):781-811. PubMed ID: 24195461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A modular platform for targeted RNAi therapeutics.
    Kedmi R; Veiga N; Ramishetti S; Goldsmith M; Rosenblum D; Dammes N; Hazan-Halevy I; Nahary L; Leviatan-Ben-Arye S; Harlev M; Behlke M; Benhar I; Lieberman J; Peer D
    Nat Nanotechnol; 2018 Mar; 13(3):214-219. PubMed ID: 29379205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delivering small interfering RNA for novel therapeutics.
    Lu PY; Woodle MC
    Methods Mol Biol; 2008; 437():93-107. PubMed ID: 18369963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA interference to enhance radiation therapy: Targeting the DNA damage response.
    Ratnayake G; Bain AL; Fletcher N; Howard CB; Khanna KK; Thurecht KJ
    Cancer Lett; 2018 Dec; 439():14-23. PubMed ID: 30240587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNAi nanomedicines: challenges and opportunities within the immune system.
    Weinstein S; Peer D
    Nanotechnology; 2010 Jun; 21(23):232001. PubMed ID: 20463388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
    Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
    Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Companies in footrace to deliver RNAi.
    Bouchie A
    Nat Biotechnol; 2012 Dec; 30(12):1154-7. PubMed ID: 23222766
    [No Abstract]   [Full Text] [Related]  

  • 35. Near-infrared light-directed RNAi using a photosensitive carrier molecule.
    Matsushita-Ishiodori Y; Morinaga M; Watanabe K; Ohtsuki T
    Bioconjug Chem; 2013 Oct; 24(10):1669-73. PubMed ID: 23998791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifunctional Oligoaminoamides for the Receptor-Specific Delivery of Therapeutic RNA.
    Weber J; Lächelt U; Wagner E
    Methods Mol Biol; 2015; 1324():369-86. PubMed ID: 26202283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
    Singh SK; Hajeri PB
    Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivery of RNAi-Based Therapeutics for Bone Regeneration.
    Malcolm DW; Wang Y; Overby C; Newman M; Benoit DSW
    Curr Osteoporos Rep; 2020 Jun; 18(3):312-324. PubMed ID: 32394316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of RNAi technology for targeted therapy--a track of siRNA based agents to RNAi therapeutics.
    Zhou Y; Zhang C; Liang W
    J Control Release; 2014 Nov; 193():270-81. PubMed ID: 24816071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.